Challenges in non-viral ocular gene transfer.

Area of Science:

• Ophthalmology
• Gene Therapy
• Biomaterials

Background:

• Effective treatments for many retinal disorders are lacking.
• Gene therapy offers a potential alternative treatment strategy for severe ocular diseases.
• Intravitreal injection is a less invasive route for delivering gene complexes to the posterior segment of the eye compared to subretinal injection.

Purpose of the Study:

• To review the behavior of non-viral gene complexes within the vitreous gel.
• To investigate the influence of poly(ethylene glycol) (PEG) coating on lipoplexes.
• To assess the impact of PEGylation on retinal pigment epithelium transfection efficiency.

Main Methods:

• Review of existing literature on non-viral gene complex behavior in the vitreous.
• Analysis of studies focusing on PEGylated lipoplexes.
• Examination of data regarding gene delivery and transfection rates in the retinal pigment epithelium.

Main Results:

• Non-viral gene complexes exhibit specific behaviors when traversing the vitreous gel.
• Poly(ethylene glycol) coating significantly alters the properties and diffusion of lipoplexes in the vitreous.
• PEGylation can enhance the ability of gene complexes to reach and transfect retinal cells.

Conclusions:

• Understanding vitreous behavior is crucial for optimizing intravitreal gene therapy.
• Poly(ethylene glycol) modification is a promising strategy to overcome intravitreal delivery barriers.
• Improved gene complex delivery via intravitreal injection holds potential for treating retinal disorders.